今天我们举行高质量完成"十四五"规划系列主题新闻发布会第五场。我们非常高兴邀请到：省委农村工作领导小组办公室主任、省农业农村厅厅长、省 乡村振兴局局长孙矿玲女士，省农业农村厅副厅长吴昱先生，渭南市政府副市长刘宝琳先生，安康市委常委、市政府常务副市长黄戈先生，杨凌示范区党工 委副书记王军先生，请他们介绍陕西"十四五"时期农业农村发展成就，并回答大家关心的问题。 下面，我们首先请孙矿玲女士作介绍。 孙矿玲：女士们、先生们，大家上午好！欢迎出席今天的新闻发布会，非常感谢媒体朋友长期以来对农业农村工作的关心和支持。 "十四五"期间，全省上下深入贯彻落实习近平总书记关于"三农"工作的重要论述和历次来陕重要讲话重要指示，全面落实党中央、国务院决策部署，学 习运用"千万工程"经验，扎实推进"七个提升工程"，坚决守牢保障粮食安全和不发生规模性返贫致贫底线，推动农业增效益、农村增活力、农民增收入，乡 村全面振兴不断取得新成效。 一是粮食和重要农产品生产能力显著增强。严格落实粮食安全党政同责，深入实施"两藏"战略，坚持良田良种良机良法集成发力，扎实推进新一轮千亿 斤粮食产能提升行动。探索建立耕地、永久基本农田和高标准农田"一体化 ...

Core Viewpoint - Yipin Group, China's second-largest goat milk powder brand, is preparing for an IPO in Hong Kong, facing scrutiny from the China Securities Regulatory Commission regarding its historical development, employee stock ownership, information security, and foreign investment access [2] Financial Performance - Yipin Group's revenue for 2022 to 2025 (H1) is reported as 1.402 billion, 1.614 billion, 1.762 billion, and 806 million yuan respectively, with corresponding net profits of 227 million, 168 million, 172 million, and 57 million yuan [3] - Revenue growth peaked at 15.17% in 2023 but is projected to slow to 9.16% in 2024, with a significant decline of 10.36% in H1 2025 [3] - Net profit saw a year-on-year decrease of 25.21% in 2023, a slight increase of 2.5% in 2024, followed by a drastic drop of 42.57% in H1 2025 [3] Product Structure - The product structure is heavily reliant on infant formula goat milk powder, which accounted for 55.1%, 57.4%, 58.6%, and 55.6% of revenue from 2022 to H1 2025 [4] - The special medical food segment has a gross margin of 76.1%, significantly higher than the overall company gross margin of 49.9%, but its smaller scale limits its impact on reducing dependency on traditional milk powder [4] Research and Development - Yipin Group's R&D expenses have decreased significantly, from 19.91 million yuan in 2022 to 8.418 million yuan in 2023, and further down to 8.014 million yuan in 2024, with the R&D expense ratio dropping from 1.42% in 2022 to 0.45% in 2024 [5] - As of June 30, the company had 322 million yuan in cash and cash equivalents against short-term borrowings of 502 million yuan, resulting in a cash coverage ratio of approximately 64% [5] Inventory Management - Inventory turnover days have increased, reported at approximately 276, 296, 307, and 361 days from 2022 to 2025, attributed to strategic decisions made in 2023 to stockpile raw materials in response to new national standards [5] Supplier and Customer Relationships - The chairman's associated company has been a major supplier for 11 years, with procurement amounts from this supplier being 47.977 million yuan in 2023, accounting for 4% of total procurement [10] - One of the top five customers is also an associated party, involved in retail distribution of Yipin Group's products in Jiangsu, maintaining a relationship for seven years [14]

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has issued supplementary material requirements for 11 companies, including Yipin Group, which is preparing for an IPO on the Hong Kong Stock Exchange. The CSRC has requested clarifications on various aspects of the company's operations and compliance [1][2]. Group 1: Company Background and Operations - Yipin Group submitted its IPO application to the Hong Kong Stock Exchange on August 31, 2025, with Haitong International and CITIC Construction Investment International as joint sponsors [1]. - The company specializes in dairy products, focusing on goat milk powder and special medical purpose formula foods, catering to consumers of all ages, particularly those with allergies, lactose intolerance, or digestive issues [3]. - Yipin Group ranks second in the Chinese goat milk powder market with a market share of 14.0%, and also holds the second position in the infant goat milk powder market with a market share of 17.6% [3]. Group 2: Regulatory Requirements - The CSRC has requested Yipin Group to clarify the fairness of the employee stock ownership plan and the compliance of retired employees holding incentive shares [2]. - The company must provide details on its app and mini-program operations, including the collection and use of personal information, as well as the scale of user data collected [2]. - Yipin Group is required to explain its overseas operations and the approval processes related to fundraising for overseas investments [2].

Core Insights - The increasing awareness and acceptance of goat milk powder among consumers, particularly young families, is driving rapid market growth due to its nutritional benefits and better absorption characteristics [1][7] - In 2024, the retail volume of infant formula goat milk powder in China is projected to reach 50,000 tons, a year-on-year increase of 5.93%, accounting for 71.43% of the total goat milk powder retail volume [1][7] - The retail value of infant formula goat milk powder is expected to reach 18.8 billion yuan, with a year-on-year growth of 8.67%, representing 75.20% of the total retail value of goat milk powder [1][7] Industry Overview - Goat milk powder is made from goat and sheep milk, which has fat globule sizes similar to human milk and a protein structure that closely resembles it, making it suitable for infants with sensitive stomachs or allergies to cow's milk [2][3] - The infant formula goat milk powder market is categorized into three stages based on the age of infants: Stage 1 (0-6 months), Stage 2 (6-12 months), and Stage 3 (12-36 months) [3] Market Policies - Recent policies in China, such as the "14th Five-Year Plan for Dairy Industry Competitiveness Enhancement" and various guidelines for rural revitalization and high-quality development, provide a favorable environment for the growth of the infant formula goat milk powder industry [4] Industry Chain - The upstream of the infant formula goat milk powder industry includes milk source (goat and sheep farming), auxiliary materials, production equipment, and packaging materials, with high-quality milk sources being crucial for product quality [5][6] - Major goat milk farming regions in China include Shaanxi, Shandong, and Henan, with some companies establishing their own farms to ensure quality and safety [5] Competitive Landscape - The domestic brands dominate the infant formula goat milk powder market, accounting for over 90% of registered products, with a high market concentration where the top five companies hold a 60.8% market share [6][8] - Companies like Ausnutria and Yipin Nutrition are key players, with Ausnutria being the first infant formula company listed in Hong Kong and having a significant global presence [8][10] Development Trends - The importance of milk sources will continue to rise, with fresh milk becoming the mainstream raw material, and companies adopting short-chain processing techniques to retain natural nutrients [10] - Innovations in formulations will focus on enhancing nutritional elements such as DHA, ARA, and probiotics, while also addressing the needs of infants with allergies through low-allergen and easily digestible products [10][11]

Overview - The demand for high-quality dairy products, particularly goat milk powder, is increasing due to rising national income levels and health awareness. Goat milk powder is favored for its rich nutrition and easy absorption, especially among the aging population and those with lactose intolerance [1][9]. Market Statistics - In 2024, China's goat milk powder retail volume is projected to reach 70,000 tons, representing a year-on-year growth of 6.87%. The retail value is expected to reach 25 billion yuan, with a year-on-year increase of 9.17% [1][9]. Industry Development - The goat milk powder industry has evolved significantly since the establishment of New China, with key milestones including the 2008 melamine food safety incident that boosted goat milk powder's popularity as a safer alternative to cow milk powder. The industry entered a rapid growth phase post-2018 with the implementation of formula registration systems [7][9]. Market Policies - Recent policies such as the "14th Five-Year Plan for Dairy Industry Competitiveness Enhancement" and various guidelines for rural revitalization and high-quality development have created a favorable environment for the growth of the goat milk powder industry [8]. Industry Chain - The goat milk powder industry chain includes upstream sources like goat farming, midstream production processes, and downstream sales channels such as supermarkets and e-commerce platforms. The consumer base is expanding to include infants, the elderly, and pregnant women [8]. Competitive Landscape - Major dairy companies like Yili, Mengniu, and Ausnutria are entering the goat milk powder market, with significant acquisitions and investments. The market concentration is increasing, with the top five companies holding a 55.6% market share in 2024 [11]. Company Profiles - Ausnutria, established in 2003 and listed in Hong Kong, is a leading player in the goat milk powder sector, with a revenue of 3.887 billion yuan and a gross profit of 1.628 billion yuan in the first half of 2025 [11][12]. - Yipin Nutrition Technology Group focuses on providing high-nutrition, easily absorbed goat milk powder for all age groups, reporting a revenue of 806 million yuan in the first half of 2025, with infant formula accounting for 55.57% of sales [13]. Future Trends - The goat milk powder industry is expected to adopt "short-chain processing" techniques and fresh-keeping technologies to retain the natural nutrients of fresh goat milk. The demand for A2 milk sources and high whey protein products is anticipated to grow, emphasizing the importance of quality and scarcity of milk sources as core competitive advantages [14].

Core Viewpoint - Yipin Nutrition Technology (Qingdao) Group Co., Ltd. has submitted an application for listing on the Hong Kong Stock Exchange, focusing on low-allergen dairy products and special medical formula foods, targeting sensitive consumer groups [1][2]. Company Overview - Yipin Nutrition's core products include low-allergen milk products, such as goat milk powder designed for allergic and lactose-intolerant individuals, and specialized medical formula foods commonly used in hospitals [1]. - The company has a long history, tracing back to 1956, and has evolved from a local dairy enterprise to a comprehensive nutrition technology group covering the entire industry chain [1][3]. - Yipin Nutrition has established its own farms in Heilongjiang and Shandong, and its Spanish factory produces one-quarter of the EU's goat whey powder [1][4]. Financial Performance - Yipin Nutrition's revenue for the years 2022, 2023, 2024, and the first half of 2025 was approximately 1.402 billion, 1.614 billion, 1.762 billion, and 806.8 million RMB, respectively [4]. - The company's annual profits during the same period were approximately 227 million, 168 million, 172 million, and 56.688 million RMB [4]. Market Dynamics - The low-allergen dairy and special medical food sectors are experiencing significant growth, driven by rising allergy rates among infants (12.3%) and increasing demand for medical nutrition due to an aging population [2][7]. - The Chinese goat milk powder market is projected to reach a retail scale of 25 billion RMB by 2024, with a compound annual growth rate (CAGR) of 4.7% from 2020 to 2024 [6]. - The special medical food market is expected to grow even faster, reaching 23 billion RMB by 2024, with a CAGR of 23.1% during the same period [6]. Competitive Landscape - Yipin Nutrition ranks second in the domestic market for infant formula goat milk powder, with a market share of 14.0% [8]. - The company has successfully narrowed the gap with international giants like Abbott and Nestlé, achieving quality standards comparable to those in Europe [8]. Future Opportunities - New entrants in the low-allergen dairy and special medical food sectors can explore three main growth areas: functional formula powders, high-end adult nutrition powders, and cross-border market expansion [9][10]. - The demand for functional formula powders is shifting towards "precision nutrition," with products targeting specific needs such as allergy and nutritional supplementation [9]. - The adult high-end nutrition powder market is projected to reach 820 million RMB by 2024, with a growth rate exceeding 28% [9].

Core Viewpoint - The Chinese milk powder market is entering a phase of segmented competition, with goat milk powder and special medical purpose formula foods becoming new focal points for capital attention. Yipin Nutrition Technology (Qingdao) Group Co., Ltd. has submitted its prospectus for an IPO on the Hong Kong Stock Exchange, attracting significant market interest. However, underlying issues such as profit volatility, underutilized production capacity, and high inventory levels pose multiple risks for the company [1]. Financial Performance - Yipin Nutrition's revenue has shown steady growth over the past three years, with figures of 1.402 billion yuan, 1.614 billion yuan, and 1.762 billion yuan from 2022 to 2024. However, net profit has experienced significant fluctuations, with net profits of 227 million yuan, 168 million yuan, and 172 million yuan during the same period, showing a notable decline in 2023. In the first half of 2025, revenue was 806 million yuan, down over 10% year-on-year, and net profit was only 57 million yuan, a decrease of over 40% [2]. - Despite a high gross margin of nearly 50% in 2023 and 2024, the company has struggled to convert this into stable profits due to rising production costs, increased sales and distribution expenses, expanded administrative costs, and asset impairment losses [2]. Sales and Expenses - Sales expenses have outpaced revenue growth, with figures of 240 million yuan, 371 million yuan, and 432 million yuan from 2022 to 2024, and growth rates of 54.58% and 16.44% in 2023 and 2024, respectively. In the first half of 2025, sales expenses continued to grow by 5.9% to 233 million yuan, despite a 10.36% decline in revenue [3]. - The increase in sales expenses is particularly driven by e-commerce platform service fees, which have become the company's largest supplier since 2023, surpassing the procurement of raw materials like fresh cow and goat milk [3]. Business Structure and Market Challenges - Yipin Nutrition's business structure is highly concentrated, with infant formula goat milk powder contributing 58.6% of revenue in 2024. The company faces challenges from declining birth rates affecting market demand for infant formula and increasing competition from established brands like Yili, Feihe, Mengniu, and Junlebao [4]. - The special medical purpose formula food segment has shown growth, with revenues of 23.76 million yuan, 130 million yuan, and 219 million yuan from 2022 to the first half of 2025, increasing its share of total revenue from 1.7% in 2022 to 16.1% in the first half of 2025. However, as a latecomer in this market dominated by international brands, Yipin Nutrition faces significant challenges in brand building and market education [4]. Operational Efficiency - The company has experienced a decline in production capacity utilization and an increase in inventory turnover days, with inventory turnover days rising from 276 days in 2022 to 361 days in the first half of 2025. Inventory value increased from 600 million yuan at the end of 2022 to 800 million yuan in mid-2025, indicating decreased inventory turnover efficiency [5]. - The net cash flow from operating activities in the first half of 2025 was 44 million yuan, a decline of approximately 61.7% compared to the same period in 2024, primarily due to increased inventory funding. The company also recognized inventory impairment losses of 12 million yuan, a 50% increase from 2024 [6]. Governance and Dividend Policy - Concerns regarding corporate governance have arisen due to the ownership structure, with the founder and associated entities holding approximately 75.11% of the shares. The company has also made several large dividend payouts prior to the IPO, including 211 million yuan in February 2023, which exceeded net profit for that period, raising questions about cash flow management and the motivations behind the IPO [7].

Core Viewpoint - Yipin Nutrition, known as China's second-largest goat milk powder company, has submitted its IPO application to the Hong Kong Stock Exchange amid intense competition in the dairy industry, but it faces challenges with declining revenue and profits due to a sluggish goat milk powder market [1] Financial Performance - In the first half of 2025, Yipin Nutrition reported a revenue of 806 million yuan, a decrease of 10.34% year-on-year, and a net profit of 56.688 million yuan, down 42.57% year-on-year [1] - From 2022 to 2024, Yipin Nutrition's revenue showed steady growth, recording 1.402 billion yuan, 1.614 billion yuan, and 1.762 billion yuan respectively, while net profit fluctuated at 227 million yuan, 168 million yuan, and 172 million yuan [1] Market Dynamics - The company's goat milk powder revenue, which constitutes a significant portion of its performance, declined by 18.6% to 448 million yuan in the first half of 2025 [1] - The product concentration is notably high, with infant formula goat milk powder revenues of 772 million yuan, 926 million yuan, and 1.033 billion yuan from 2022 to 2024, accounting for 55.1%, 57.4%, and 58.6% of total revenue respectively [1] Cost Structure - Yipin Nutrition's operating cash flow net amount dropped by over 60% year-on-year, while all three major expenses (selling, administrative, and financial) increased, particularly sales expenses [1] - Despite the financial strain, the company has reduced its already low R&D expenses further [1] Dividend Policy - Prior to the IPO, Yipin Nutrition has frequently issued large dividends, which coincided with a significant drop in net profit of over 40% [1]

Core Viewpoint - Yipin Group, the second-largest goat milk powder brand in China, has officially submitted its IPO application to the Hong Kong Stock Exchange, drawing attention to the company's vice president, Yu Haixia [1][3]. Financial Performance - Yipin Group's revenue for 2022, 2023, and 2024 is projected to be 1.4 billion yuan, 1.61 billion yuan, and 1.76 billion yuan respectively, with net profits of 227 million yuan, 168 million yuan, and 172 million yuan [3][4]. - In the first half of this year, Yipin Group reported revenue of 806 million yuan, a decrease of 10.34% compared to 899 million yuan in the same period last year, with profits dropping by 42.42% from 98.7 million yuan to 56.7 million yuan [3][5]. Product Performance - The core product, infant formula goat milk powder, accounted for over 50% of Yipin Group's revenue from 2022 to 2024, with revenues of 772 million yuan, 926 million yuan, and 1.03 billion yuan respectively, indicating steady growth [4]. - However, in the first half of this year, revenue from infant formula goat milk powder was 448 million yuan, down 18.5% from 550 million yuan in the same period last year [5]. Market Position - Yipin Group holds a 14.0% market share in the domestic goat milk powder market, ranking second, only behind Ausnutria's Kabrita [4]. Management Background - Yu Haixia, the vice president of Yipin Group, has a diverse work history, including roles in marketing and management across various companies, which contributes to her extensive management experience [6][7][8].

Core Viewpoint - Yipin Nutrition Technology (Qingdao) Group Co., Ltd. has submitted its IPO application to the Hong Kong Stock Exchange, focusing on nutritional products for infants with allergic conditions [2][5]. Group 1: Business Overview - Yipin's product line addresses the nutritional needs of infants with allergies, offering cow and goat milk formulas, as well as specialized medical foods for varying levels of allergies [2]. - The company holds a 14% market share in China's goat milk powder market, ranking second, and a 4.5% share in the infant specialized medical food market, also ranking second among local brands [2]. Group 2: Financial Performance - In 2024, Yipin's revenue is projected to be 1.76 billion yuan, with a growth rate slowing from 15% to 9.2% year-on-year [3]. - Revenue for the first half of 2025 fell by 10% to 810 million yuan, with a significant decline in net profit exceeding 40% [3]. - The company's return on equity has dropped from 30% in 2022 to 11% in the first half of 2025 due to increased investments in the supply chain [4]. Group 3: Market Challenges - The overall growth of the milk powder industry is slowing, with the goat milk powder market experiencing stagnation and a decline in sales [7][8]. - Yipin's goat milk powder revenue has only seen single-digit growth, and competition from cow milk brands is intensifying as they introduce easier-to-digest products [8]. Group 4: Strategic Initiatives - Yipin has expanded its dealer network significantly, with the number of dealers reaching 2,119 by mid-2025, nearly doubling since 2022 [10]. - The company is focusing on the specialized medical food segment, which has shown a compound annual growth rate of over 200% and accounted for 16.1% of total revenue by mid-2025 [13]. Group 5: Production and Supply Chain - Yipin operates its own goat milk farms and has established multiple production facilities, including a new factory in Qingdao with an annual capacity exceeding 16,000 tons [19][20]. - However, the average capacity utilization rate of its domestic factories dropped to 44.5% in the first half of 2025, indicating challenges in absorbing new production capacity [22]. Group 6: Future Outlook - The company aims to enter the adult functional nutrition market and expand its overseas presence, although its R&D spending remains low compared to competitors [17]. - Yipin is also working on increasing its self-sufficiency in milk supply, with new farms expected to come online in the coming years [25].